Indian Pharmaceutical Alliance
Lobbying group · Jul 2025 – Sep 2026
Indian Pharmaceutical Alliance spent $2.7M lobbying the federal government (Jul 2025 – Sep 2026), mostly on health care, trade.
- Spent on lobbying
- $2.7M
- Issues
- 2
Spending by quarter
- 2025 Q3$15K
- 2025 Q4$900K
- 2026 Q1$900K
- 2026 Q2$900K
Issues lobbied
- Health care
- Trade
Lobbying firms hired
- Medsecurean.Com$2.7M
Agencies contacted
- Health & Human Services, Dept of (Hhs) · 7
- House Of Representatives · 7
- Senate · 7
- State, Dept of (Dos) · 6
- U.S. Trade Representative (Ustr) · 6
- White House Office · 6
Related
Filings
- 2026 Q2 report$900K
- 2026 Q1 report$900K
- 2025 Q4 report$900K
- 2025 Q3 report$15K
From Lobbying Disclosure Act reports filed with the Senate and House.
Cite or embed this page
Capitol Receipts, “Indian Pharmaceutical Alliance: Lobbying Spending, Issues & Bills,” https://www.capitolreceipts.com/lobbying/cindianpharmaceuticalalliance/indian-pharmaceutical-alliance (accessed 2026-10-16).